TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/17/2026
Back to search
Official data from USPTO
KINASET THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KINASET THERAPEUTICS
ST13
US500000090978226Class
42
Filing
90978226
Registration
6902992
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/19/2026
Trademark type
Word
Nice classes
42
Filing date
12/14/2020
Registration date
11/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
04/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-11-00
First use in commerce
2020-11-00
Drawing code
4
Owner type
03
Owner location
Medfield, MA, US
Examiner
STRUCK, ROBERT J
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kinaset Therapeutics, Inc.
Representatives
Jessica L. Rothstein Goodwin Procter LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceuticals and therapeutics
Publications
History of USPTO decisions and trademark events.
33 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/17/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/17/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/17/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/17/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/14/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/13/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/22/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
09/22/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/21/2022
IUAF
USE AMENDMENT FILED
09/06/2022
DRRR
DIVISIONAL REQUEST RECEIVED
09/06/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/06/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/06/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/25/2022
PUBO
PUBLISHED FOR OPPOSITION
01/25/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/05/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/02/2021
ALIE
ASSIGNED TO LIE
12/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2021
GNRT
NON-FINAL ACTION E-MAILED
06/15/2021
CNRT
NON-FINAL ACTION WRITTEN
06/15/2021
DOCK
ASSIGNED TO EXAMINER
06/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2021
NWAP
NEW APPLICATION ENTERED
12/17/2020
Continuous trademark protection
Get notified about every new filing that threatens KINASET THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.